Published in Infect Immun on July 01, 2005
Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol (2009) 3.94
Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun (2006) 1.51
The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine (2007) 1.49
Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect Immun (2008) 1.35
Characterization of virulence of Leptospira isolates in a hamster model. Vaccine (2008) 1.32
In LipL32, the major leptospiral lipoprotein, the C terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin. Infect Immun (2008) 1.31
Leptospirosis vaccines. Microb Cell Fact (2007) 1.11
A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans. PLoS Negl Trop Dis (2011) 0.92
Subunit approach to evaluation of the immune protective potential of leptospiral antigens. Clin Vaccine Immunol (2011) 0.91
OmpL1 is an extracellular matrix- and plasminogen-interacting protein of Leptospira spp. Infect Immun (2012) 0.91
Characterization of the immunogenic and antigenic potential of putative lipoproteins from Leptospira interrogans. Curr Microbiol (2011) 0.91
Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin. Clin Vaccine Immunol (2012) 0.89
Serum activity of platelet-activating factor acetylhydrolase is a potential clinical marker for leptospirosis pulmonary hemorrhage. PLoS One (2009) 0.87
Increased immunogenicity to LipL32 of Leptospira interrogans when expressed as a fusion protein with the cholera toxin B subunit. Curr Microbiol (2010) 0.85
Analysis of multiple Leptospira interrogans serovar Canicola vaccine proteomes and identification of LipL32 as a biomarker for potency. Clin Vaccine Immunol (2012) 0.84
Calcium binding to leptospira outer membrane antigen LipL32 is not necessary for its interaction with plasma fibronectin, collagen type IV, and plasminogen. J Biol Chem (2011) 0.83
A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis. Clin Vaccine Immunol (2013) 0.83
'Spotted Nanoflowers': Gold-seeded Zinc Oxide Nanohybrid for Selective Bio-capture. Sci Rep (2015) 0.83
A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis. Clin Vaccine Immunol (2013) 0.80
Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45. Hum Vaccin Immunother (2015) 0.79
High yield expression of leptospirosis vaccine candidates LigA and LipL32 in the methylotrophic yeast Pichia pastoris. Microb Cell Fact (2010) 0.79
Protective Immunity and Reduced Renal Colonization Induced by Vaccines Containing Recombinant Leptospira interrogans Outer Membrane Proteins and Flagellin Adjuvant. Clin Vaccine Immunol (2015) 0.76
DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis. Mem Inst Oswaldo Cruz (2015) 0.76
Reverse Vaccinology: An Approach for Identifying Leptospiral Vaccine Candidates. Int J Mol Sci (2017) 0.76
Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar canicola in hamsters. Clin Vaccine Immunol (2014) 0.76
Development of transcriptional fusions to assess Leptospira interrogans promoter activity. PLoS One (2011) 0.76
Crystallization and preliminary X-ray analysis of LipL32 from Leptospira interrogans serovar Copenhageni. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.75
LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis. PLoS Negl Trop Dis (2017) 0.75
Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate. PLoS One (2015) 0.75
Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis. PLoS One (2017) 0.75
Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology. Front Immunol (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Leptospirosis. Clin Microbiol Rev (2001) 18.25
Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis (2003) 15.02
Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet (1999) 7.90
NUTRITION OF LEPTOSPIRA POMONA AND GROWTH OF 13 OTHER SEROTYPES: FRACTIONATION OF OLEIC ALBUMIN COMPLEX AND A MEDIUM OF BOVINE ALBUMIN AND POLYSORBATE 80. Am J Vet Res (1965) 6.99
DNA vaccines: immunology, application, and optimization*. Annu Rev Immunol (2000) 4.51
The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun (2000) 3.50
Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis (1999) 2.63
Spirochaetal lipoproteins and pathogenesis. Microbiology (2000) 2.30
Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect Immun (1997) 2.05
Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. J Clin Microbiol (2001) 1.91
Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect Immun (2002) 1.89
Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun (2001) 1.56
Characterization of outer membrane and secreted proteins of Leptospira interrogans serovar pomona. Microb Pathog (1991) 1.56
Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence. Infect Immun (1997) 1.50
Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Biochemistry (1999) 1.48
Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine (2000) 1.42
Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur J Immunol (1995) 1.36
Molecular analysis of a sphingomyelinase C gene from Leptospira interrogans serovar hardjo. Infect Immun (1990) 1.35
Rapid translocation of polarized MDCK cell monolayers by Leptospira interrogans, an invasive but nonintracellular pathogen. Infect Immun (2002) 1.29
Identification and partial characterization of a novel hemolysin from Leptospira interrogans serovar lai. Gene (2000) 1.16
Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infect Immun (2001) 1.14
The significance of leptospiral hemolysin in the pathogenesis of Leptospira pomona infections. J Infect Dis (1961) 1.08
Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Tania ovis 45W antigen. Vaccine (2000) 1.03
Leptospira interrogans activation of human peripheral blood mononuclear cells: preferential expansion of TCR gamma delta+ T cells vs TCR alpha beta+ T cells. J Immunol (2003) 1.00
Evaluation of type 1 immune response in naïve and vaccinated animals following challenge with Leptospira borgpetersenii serovar Hardjo: involvement of WC1(+) gammadelta and CD4 T cells. Infect Immun (2002) 0.99
Hantavirus and Leptospira. Lancet (1988) 0.98
Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O. J Immunol (1999) 0.97
Infertility and abortion among first-lactation dairy cows seropositive or seronegative for Leptospira interrogans serovar hardjo. J Am Vet Med Assoc (1999) 0.97
Polymerase chain reaction assay specific for pathogenic Leptospira based on the gene hap1 encoding the hemolysis-associated protein-1. FEMS Microbiol Lett (2005) 0.95
Comparison of three different leptospiral vaccines for induction of a type 1 immune response to Leptospira borgpetersenii serovar Hardjo. Vaccine (2003) 0.94
Site-specific mutagenesis of Clostridium perfringens alpha-toxin: replacement of Asp-56, Asp-130, or Glu-152 causes loss of enzymatic and hemolytic activities. Infect Immun (1997) 0.94
Leptospirosis in an urban setting: case report and review of an emerging infectious disease. J Emerg Med (1999) 0.93
Stillbirth/perinatal weak calf syndrome: a study of calves infected with Leptospira. Vet Rec (1999) 0.92
Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia. J Vet Med Sci (1997) 0.91
Incidence of leptospiral abortion in Brazilian dairy cattle. Prev Vet Med (1999) 0.91
In vitro studies of haemolysis by Leptospira interrogans serovars pomona and ballum. Vet Microbiol (1986) 0.90
Secretion of different listeriolysin cognates by recombinant attenuated Salmonella typhimurium: superior efficacy of haemolytic over non-haemolytic constructs after oral vaccination. Microbes Infect (2000) 0.89
Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani. Vaccine (2003) 0.87
DNA vaccines. Curr Mol Med (2001) 0.87
Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses. FEMS Immunol Med Microbiol (2003) 0.87
Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis. Vet Rec (2003) 0.85
Chronic hepatitis associated with leptospiral infection in vaccinated beagles. J Comp Pathol (1997) 0.85
Recognition of Leptospira interrogans antigens by vaccinated or infected dogs. Vet Microbiol (1994) 0.84
Swine leptospirosis: low risk of exposure for humans? Can Vet J (1999) 0.82
Nucleic acid vaccines: research tool or commercial reality. Vet Immunol Immunopathol (2000) 0.82
Immunoblotting study of the antigenic relationships among eight serogroups of Leptospira. Vet Microbiol (1992) 0.81
Demonstration by mass spectrometry that purified native Treponema pallidum rare outer membrane protein 1 (Tromp1) has a cleaved signal peptide. J Bacteriol (1999) 0.80
Role of the coypu (Myocastor coypus) in the epidemiology of leptospirosis in domestic animals and humans in France. Eur J Epidemiol (2001) 0.79
Occupational hazard of unnoticed leptospirosis in water ways maintenance staff. Eur J Epidemiol (1992) 0.79
Current status of DNA vaccines and their route of administration. Crit Rev Ther Drug Carrier Syst (2002) 0.79
HlyC, the internal protein acyltransferase that activates hemolysin toxin: roles of various conserved residues in enzymatic activity as probed by site-directed mutagenesis. Biochemistry (1999) 0.78
Haemolysin A and listeriolysin--two vaccine delivery tools for the induction of cell-mediated immunity. Int J Parasitol (2003) 0.77
Plasmid DNA vaccines. Immunology, tolerance, and autoimmunity. Mol Biotechnol (2001) 0.76
Excess weight risk factor for alcoholic liver disease. Hepatology (1997) 2.22
Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection. Vet Immunol Immunopathol (1995) 2.21
Hes1 and Hes5 activities are required for the normal development of the hair cells in the mammalian inner ear. J Neurosci (2001) 2.07
Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc (2001) 1.94
A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology (1991) 1.70
Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun (2001) 1.56
Binding of rabbit hemorrhagic disease virus to antigens of the ABH histo-blood group family. J Virol (2000) 1.49
Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression. AIDS (2000) 1.44
Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine (2000) 1.42
[Transparietal spontaneous migration: a complication related to the use of a new material of percutaneous endoscopic gastrostomy?]. Gastroenterol Clin Biol (1994) 1.37
Noninvasive assessment of seasonal variations in cardiac structure and function in cyclists. Circulation (1983) 1.29
Three-dimensional morphology of the distal part of the femur viewed in virtual reality. J Bone Joint Surg Am (2001) 1.20
Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis. Eur Respir J (2007) 1.18
Cardiac structure and function in cyclists and runners. Comparative echocardiographic study. Br Heart J (1984) 1.09
Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland. Virus Res (1991) 1.06
Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis. Endoscopy (2009) 1.06
Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer. Eur Respir J (2005) 1.04
Analysis of major repetitive DNA sequences in the dog (Canis familiaris) genome. Mamm Genome (1999) 1.03
Modulation of social interactions by immune stimulation in honey bee, Apis mellifera, workers. BMC Biol (2008) 1.00
Effects of forearm pronation/supination on carpal tunnel pressure. J Hand Surg Am (1998) 1.00
Effects of finger posture on carpal tunnel pressure during wrist motion. J Hand Surg Am (1998) 0.97
Fingertip loading and carpal tunnel pressure: differences between a pinching and a pressing task. J Orthop Res (1998) 0.97
Mechanisms of the behavioural effects of cytokines. Adv Exp Med Biol (1999) 0.94
Susceptibility to subchronic unpredictable stress is related to individual reactivity to threat stimuli in mice. Behav Brain Res (2004) 0.91
Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol. Br Med J (1970) 0.90
Diagnostic value of serum gamma-glutamyl-transferase activity and mean corpuscular volume in alcoholic patients with or without cirrhosis. Alcohol Clin Exp Res (1990) 0.90
Long-term results of treatment of vascular malformations of the gastrointestinal tract by neodymium YAG laser photocoagulation. Dig Dis Sci (1990) 0.90
Early morphofunctional plasticity of microglia in response to acute lipopolysaccharide. Brain Behav Immun (2013) 0.89
Phlegmonous gastritis associated with HIV-1 seroconversion. Endoscopic and microscopic evolution. Dig Dis Sci (1992) 0.89
Cross sectional echocardiographic assessment of great artery diameters in infants and children. Br Heart J (1987) 0.89
Clustered cases of leptospirosis in Rochefort, France, June 2001. Euro Surveill (2002) 0.88
SAG-2 oral rabies vaccine. Onderstepoort J Vet Res (1993) 0.87
Flexor muscle incursion into the carpal tunnel: a mechanism for increased carpal tunnel pressure? Clin Biomech (Bristol, Avon) (2000) 0.86
Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe. Vaccine (1996) 0.86
Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats. Vaccine (1991) 0.86
Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine. J Am Vet Med Assoc (1991) 0.86
Partial characterization of the human erythrocyte receptor for rabbit haemorrhagic disease virus. Res Virol (1995) 0.85
Chronic hepatitis associated with leptospiral infection in vaccinated beagles. J Comp Pathol (1997) 0.85
Effects of computer mouse design and task on carpal tunnel pressure. Ergonomics (1999) 0.84
Recognition of Leptospira interrogans antigens by vaccinated or infected dogs. Vet Microbiol (1994) 0.84
Ethological validation and the assessment of anxiety-like behaviours: methodological comparison of classical analyses and structural approaches. Behav Processes (2004) 0.84
Safety and efficacy of a recombinant FeLV vaccine combined with a live feline rhinotracheitis, calicivirus and panleukopenia vaccine. Vet Rec (2000) 0.84
Review of the reviewer. Pacing Clin Electrophysiol (1995) 0.84
Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse. Immunol Lett (2006) 0.84
Characterization of group EF-4 bacteria from the oral cavity of dogs. Vet Microbiol (1995) 0.83
FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection. Vet Immunol Immunopathol (1995) 0.83
[Seroprevalence of Lyme Borreliosis and tick-borne encephalitis in workers at risk, in eastern France]. Med Mal Infect (2008) 0.83
Functional canine dendritic cells can be generated in vitro from peripheral blood mononuclear cells and contain a cytoplasmic ultrastructural marker. J Immunol Methods (2005) 0.83
Abolishment of chronic volume overload. Implications for diastolic function of the systemic ventricle immediately after Fontan repair. Circulation (1992) 0.82
Early events in lymph nodes during infection with SIV and FIV. Res Virol (1995) 0.82
Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus. Vet Immunol Immunopathol (1992) 0.82
Influence of beta 1- versus beta 2-adrenoceptor blockade on left ventricular function in humans. J Cardiovasc Pharmacol (1986) 0.82
Cirrhosis as an independent risk factor for colonic adenomas. Gut (1992) 0.81
Differential modulation of spontaneous and evoked neurotransmitter release from hair cells: some novel hypotheses. Hear Res (1991) 0.81
Vaccination of Tunisian dogs with the lyophilised SAG2 oral rabies vaccine incorporated into the DBL2 dog bait. Vet Res (2000) 0.81
DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus. Vaccine (1997) 0.81
Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins. AIDS Res Hum Retroviruses (1998) 0.81
Successful treatment by mesocaval anastomosis of a common-bile-duct compression by choledochal varices. J Hepatol (1995) 0.81
Immunoblotting study of the antigenic relationships among eight serogroups of Leptospira. Vet Microbiol (1992) 0.81
FIV vaccine studies. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets. Vet Immunol Immunopathol (1995) 0.80
Oral immunization of foxes with avirulent rabies virus mutants. Vet Microbiol (1990) 0.80
Safety evaluation of the SAG2 rabies virus mutant in Tunisian dogs and several non-target species. Vet Res (1999) 0.80
Efficacy of SAG-2 oral rabies vaccine in two species of jackal (Canis adustus and Canis mesomelas). Vaccine (1999) 0.80
[Descriptive epidemiology of patients with alcoholic liver disease hospitalized in a hepato-gastroenterology service]. Gastroenterol Clin Biol (1999) 0.80
Innocuity studies of SAG-2 oral rabies vaccine in various Zimbabwean wild non-target species. Vaccine (1997) 0.80
[Biological diagnosis of the type of liver disease in alcoholic patients with abnormal liver function tests]. Gastroenterol Clin Biol (1999) 0.79
The disulfide structures of scrambled hirudins. J Biol Chem (1995) 0.79
Role of the coypu (Myocastor coypus) in the epidemiology of leptospirosis in domestic animals and humans in France. Eur J Epidemiol (2001) 0.79
Vaccination of cats with recombinant envelope glycoprotein of feline immunodeficiency virus: decreased viral load after challenge infection. AIDS Res Hum Retroviruses (1996) 0.79
Corticosterone regulates behavioral effects of lipopolysaccharide and interleukin-1 beta in mice. Am J Physiol (1995) 0.79
Rectal and colonic varices in cirrhosis. Lancet (1989) 0.79
Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology (1991) 0.78
A 270 degree laparoscopic posterior fundoplasty in the treatment of gastroesophageal reflux. J Am Coll Surg (1995) 0.78
[Videolaparoscopic treatment of paraesophageal hiatal hernia]. Chirurgie (1998) 0.78
[A study of two cases of intrathoracic hepatic heterotopia (author's transl)]. Ann Chir Thorac Cardiovasc (1975) 0.78
Closed chest myocardial biopsies: clinical uses and related problems. Acta Cardiol (1986) 0.77
Serum apolipoprotein A-I in alcoholic patients with chronic calcifying pancreatitis. Pancreas (1990) 0.77
Development of a genetically engineered vaccine against feline leukemia virus infection. J Am Vet Med Assoc (1991) 0.77
Synthetic peptide issued from Hap1/LipL32 for new early serodiagnosis of human leptospirosis. Comp Immunol Microbiol Infect Dis (2009) 0.77
Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patients. Alcohol Clin Exp Res (1989) 0.76
Dramatic improvement in survival after lung transplantation over time: a single center experience. Transplant Proc (2009) 0.76
Prevalence of cholelithiasis according to alcoholic liver disease: a possible role of apolipoproteins AI and AII. Alcohol Clin Exp Res (1995) 0.76
Attempt to modify the immune response developed against FIV gp120 protein by preliminary FIV DNA injection. Vaccine (1999) 0.76
Effects of diltiazem versus nifedipine on lower esophageal sphincter pressure in patients with progressive systemic sclerosis. Arthritis Rheum (1986) 0.76
Prevalence of the FVQ506 (factor V Leiden) mutation in the normal and thrombophilic Algerian population. Br J Haematol (1997) 0.76
Assignation of highly polymorphic markers on a canine purebred pedigree. Mamm Genome (2000) 0.75
[Laparoscopic cholecystectomy and lithiasis of the common bile duct: prospective study on the importance of preoperative endoscopic ultrasonography and endoscopic retrograde cholangiography]. Gastroenterol Clin Biol (1998) 0.75
[Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study]. Wien Klin Wochenschr (1990) 0.75
Evaluation of transmitral pressure gradients at different heart rates: divergent action of isoprenaline and atropine. Cardiovasc Res (1990) 0.75
[Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients]. Gastroenterol Clin Biol (1988) 0.75
Leptospirosis in domestic animals in France: serological results from 1988 to 2007. Rev Sci Tech (2016) 0.75
Characterization and mapping of canine polymorphic markers. Anim Genet (1999) 0.75
Comparison of angiographic methods for the assessment of the extent of experimental anterior myocardial infarction in dog hearts. Int J Cardiol (1990) 0.75
[Evaluation of hepatitis B vaccination in a Paris hospital personnel. 386 subjects]. Presse Med (1987) 0.75
[MRI cholangiography with rapid spin-echo technique: prospective evaluation of 20 patients]. J Radiol (1998) 0.75
[Acute icteric viral hepatitis type A, B, D and non-A non-B. Etiologic, clinical and developmental aspects in the young man. Apropos of 423 cases]. Gastroenterol Clin Biol (1990) 0.75